Professional Summary

Professional Overview

Anne Dolman is an experienced Associate Director in CMC (Chemistry, Manufacturing, and Controls) Project Management, with a strong background in the pharmaceutical and biotechnology industries. She specializes in leading complex CMC projects and initiatives, driving successful outcomes for her clients.

Experience Summary

Current Role

As the Associate Director of CMC Project Management at EyeBio, Anne is responsible for overseeing the execution of critical CMC projects, ensuring seamless collaboration between cross-functional teams and adherence to regulatory requirements. She is instrumental in driving the development and commercialization of innovative ophthalmic therapeutics, contributing to the company's growth and patient-centric mission.

Career Progression

Anne's career trajectory has been marked by progressive experience and leadership roles in CMC project management. Prior to her current position, she served as a CMC Project Manager at invoX Pharma and F-star, an invoX company, where she demonstrated her ability to navigate complex pharmaceutical development processes. Anne also held CMC Project Manager and Project Leader roles at Sanofi, where she made significant contributions to the successful advancement of multiple drug candidates.

Earlier in her career, Anne gained valuable experience as a Senior CMC Project Manager and CMC Manager at Kymab Ltd, as well as a Project Manager (CMC) and Associate Project Manager (CMC) at MedImmune. She also held research scientist and research assistant roles, providing her with a deep understanding of downstream processing and drug development.

Academic Background

Anne holds a Bachelor of Science degree in Biochemistry from the University of Cambridge, where she graduated with Honors. Her academic focus and research experience have equipped her with a strong foundation in the scientific principles underlying pharmaceutical development.

Areas of Expertise

• Comprehensive CMC project management expertise, including planning, execution, and oversight

• Extensive knowledge of biopharmaceutical manufacturing processes and quality control

• Exceptional cross-functional collaboration and stakeholder management skills

• Proficiency in navigating regulatory requirements and guidelines

• Proven track record of successful CMC project delivery and problem-solving

Professional Impact

Throughout her career, Anne has made significant contributions to the advancement of various drug candidates, from early-stage development to commercialization. Her leadership in CMC project management has been instrumental in driving the successful progression of multiple innovative ophthalmic therapeutics, ultimately benefiting patients and the industry.

Conclusion

With her extensive experience, deep technical expertise, and demonstrated leadership in CMC project management, Anne Dolman is a valuable asset to the pharmaceutical and biotechnology industries. Her dedication to delivering successful outcomes and her commitment to advancing patient care make her a highly sought-after professional in the field.